How does a patient find an acute myeloid leukemia expert?

Is it appropriate and when is it appropriate for someone to receive a second opinion for their acute myeloid leukemia?

What should an acute myeloid leukemia patient consider when deciding on a treatment option?

How are treatment plans developed for patients with acute myeloid leukemia?

What are some of the treatment strategies patients with acute myeloid leukemia should understand and be prepared for?

What is remission?

How have treatments for acute myeloid leukemia evolved over the years?

What are some of the major side effects of treatment that patients should be prepared for?

If we are able to identify and target someone's AML genetics, why is AML still difficult to get rid of?

What are the gene mutations that we currently have targeted drugs for?

Which gene mutations are categorized as low, intermediate and high risk AML?

What is next generation sequencing (NGS)?

What are cytogenetics and what does it tell us about someone's AML?

What are epigenetics?

What does the term genetics mean, and why is it relevant to patients with AML?

What is clonal evolution?

What is FLT3 positive AML? What is gilteritinib?

When during a course of treatment is gilteritinib used to treat FLT3 positive AML?

What research is being done with gliteritinib to make this therapy more effective?

Can gilteritinib cure AML?

What type of cells are affected in acute myeloid leukemia?

What testing is most important to monitor acute myeloid leukemia over time?

What is genetic testing and what can it tell you about someone’s acute myeloid leukemia?